GeorgeF.WootenMD

Neurology • Charlottesville, VA

Professor of Neurology, University VA School of Medicine

Join to view full profile

Dr. Wooten is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wooten's full profile

Already have an account?

Office
1215 Hospital Dr
Charlottesville, VA 22908
Phone+1 434-924-9333

Fax+1 434-982-0049
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1974 - 1977
University of California (San Francisco)Internship, Internal Medicine, 1970 - 1971
Weill Cornell MedicineClass of 1970

Certifications & Licensure

VA State Medical License 1971 - 2018
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

1 citations
Capgras Syndrome in Advanced Parkinson’s Disease
Christopher L. Groth, Antonia Pusso, Scott A. Sperling, Diane S. Huss, W. Jeffrey Elias, G. Frederick Wooten, Matthew J. Barrett> ;The Journal of Neuropsychiatry and Clinical Neurosciences. 2017 Nov 14
2 citations
MM1-Type Sporadic Creutzfeldt-Jakob Disease With Early Behavioral Changes and Prolonged Symptom Duration.
Jason L. Crowell, G. Frederick Wooten, Matthew J. Barrett> ;The Journal of Neuropsychiatry and Clinical Neurosciences. 2016 Apr 19
11 citations
Relationship of age of onset and family history in Parkinson disease
Matthew J. Barrett, Nicholas E. F. Hać, Guofen Yan, Madaline B. Harrison, G. Frederick Wooten> ;Movement Disorders. 2015 Apr 15
28 citations
Mortality in Levodopa-Treated Parkinson's Disease
John C. Morgan, Lillian J. Currie, Madaline B. Harrison, James P. Bennett, Joel M. Trugman, G. Frederick Wooten> ;Parkinson's Disease. 2014 Jan 28
41 citations
Differential susceptibility to motor impulsivity among functional subtypes of Parkinson’s disease
Scott A. Wylie, Wery P. M. van den Wildenberg, K. Richard Ridderinkhof, Daniel O. Claassen, G.F. Wooten, Carol A. Manning> ;Journal of Neurology, Neurosurgery, and Psychiatry. 2012 Dec 1
9 citations
Hypertrophic olivary degeneration.
Michiko Kimura Bruno, G. Frederick Wooten> ;Archives of Neurology. 2012 Feb 13
59 citations
Handedness and motor symptom asymmetry in Parkinson's disease
Matthew J. Barrett, Scott A. Wylie, Madaline B. Harrison, G. Frederick Wooten> ;Journal of Neurology, Neurosurgery, and Psychiatry. 2011 Oct 1
72 citations
The risky business of dopamine agonists in Parkinson disease and impulse control disorders.
Daniel O. Claassen, Wery P. M. van den Wildenberg, K. Richard Ridderinkhof, Charles K Jessup, Madaline B. Harrison, G. Frederick Wooten, Scott A. Wylie> ;Behavioral Neuroscience. 2011 Aug 1
Central nervous system involvement in axonal Charcot-Marie-Tooth disease.
Xinli Du, G. Frederick Wooten, Julie A. Matsumoto, Lawrence H. Phillips> ;Muscle & Nerve. 2010 Jan 1
72 citations
The effect of speed-accuracy strategy on response interference control in Parkinson's disease
Scott A. Wylie, W.P.M. van den Wildenberg, K.R. Ridderinkhof, Theodore R. Bashore, V.D. Powell, Carol A. Manning, G.F. Wooten> ;Neuropsychologia. 2009 Jul 1
66 citations
UPDRS activity of daily living score as a marker of Parkinson's disease progression.
Madaline B. Harrison, Scott A. Wylie, Robert C. Frysinger, James T. Patrie, Diane S. Huss, Lillian J. Currie, G. Frederick Wooten> ;Movement Disorders. 2009 Jan 30
10 citations
Autosomal dominant subcortical gliosis presenting as frontotemporal dementia.
Russell H. Swerdlow, Bradley Miller, M.B.S. Lopes, J. W. Mandell, G. F. Wooten, P. Damgaard, Carol A. Manning, M. Fowler, H. R. Brashear> ;Neurology. 2009 Jan 20
99 citations
The effect of Parkinson's disease on interference control during action selection
Scott A. Wylie, W.P.M. van den Wildenberg, K.R. Ridderinkhof, Theodore R. Bashore, V.D. Powell, Carol A. Manning, G.F. Wooten> ;Neuropsychologia. 2009 Jan 1
79 citations
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
Jeanne C. Latourelle, Mei Sun, Mark F. Lew, Oksana Suchowersky, Christine Klein, Lawrence I. Golbe, Margery H. Mark, John H. Growdon, G. Frederick Wooten, Ray L. Watts...> ;BMC Medicine. 2008 Nov 5
5 citations
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study
Christopher F. McNicoll, Jeanne C. Latourelle, Marcy E. MacDonald, Mark F. Lew, Oksana Suchowersky, Christine Klein, Lawrence I. Golbe, Margery H. Mark, John H. Growdo...> ;Movement Disorders. 2008 Aug 15
83 citations
Haplotypes and Gene Expression Implicate the Mapt Region for Parkinson Disease: the GenePD Study
J. E. Tobin, Jeanne C. Latourelle, Mark F. Lew, Christine Klein, Oksana Suchowersky, Holly A. Shill, Lawrence I. Golbe, Margery H. Mark, John H. Growdon, G. F. Wooten,...> ;Neurology. 2008 Jul 1
8 citations
Validity, sensitivity and specificity of the mentation, behavior and mood subscale of the UPDRS.
Suzanne Holroyd, Lillian J. Currie, G. Frederick Wooten> ;Neurological Research. 2008 Jun 1
25 citations
G2019S mutation in the leucine‐rich repeat kinase 2 gene is not associated with multiple system atrophy
Laurie J. Ozelius, Tatiana Foroud, Susanne May, Geetha Senthil, Paola Sandroni, Phillip A. Low, Stephen G. Reich, Amy Colcher, Matthew B. Stern, William G. Ondo, Josep...> ;Movement Disorders. 2007 Mar 15
170 citations
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
Karl Kieburtz, Bernard Ravina, Wendy R. Galpern, Barbara C. Tilley, Kathleen M. Shannon, Caroline M. Tanner, G. Frederick Wooten, Robert W. Hamill, Jacob I. Sage, Emil...> ;Neurology. 2007 Jan 2
26 citations
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.
Jemma B. Wilk, J. E. Tobin, Oksana Suchowersky, Holly A. Shill, Christine Klein, G. F. Wooten, Mark F. Lew, Margery H. Mark, Mark Guttman, Ray L. Watts, Carlos Singer,...> ;Neurology. 2006 Dec 26
48 citations
Preliminary FMRI evidence of visual system dysfunction in Parkinson's disease patients with visual hallucinations.
Suzanne Holroyd, G. Frederick Wooten> ;The Journal of Neuropsychiatry and Clinical Neurosciences. 2006 Jul 1
113 citations
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.
Mei Sun, Jeanne C. Latourelle, G. Frederick Wooten, Mark F. Lew, Christine Klein, Holly A. Shill, Lawrence I. Golbe, Margery H. Mark, Brad A. Racette, Joel S. Perlmutt...> ;Archives of Neurology. 2006 Jun 1
55 citations
Optimizing the ongoing search for new treatments for Parkinson disease: Using futility designs
Barbara C. Tilley, Yuko Y. Palesch, Karl Kieburtz, Bernard Ravina, Peng Huang, Jordan J. Elm, Kathleen L. Shannon, G. F. Wooten, Caroline M. Tanner, G. C. Goetz> ;Neurology. 2006 Mar 14
59 citations
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study
Samer Karamohamed, Jeanne C. Latourelle, Brad A. Racette, Joel S. Perlmutter, G. F. Wooten, Mark F. Lew, Christine Klein, Holly A. Shill, Lawrence I. Golbe, Margery H....> ;Neurology. 2005 Dec 13
179 citations
Diagnosis and Initial Management of Parkinson's Disease
John G. Nutt, G. Frederick Wooten> ;The New England Journal of Medicine. 2005 Sep 8
Join now to see all